Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


After Acticon Approval, AMS Looks To Biodegradable Stent For BPH

This article was originally published in The Gray Sheet

Executive Summary

American Medical Systems, following the Dec. 18 PMA approval of its Acticon neosphincter for severe fecal incontinence, says it will focus development efforts going forward on the BioFlow biodegradable stent for benign prostatic hyperplasia

You may also be interested in...

Curon’s Secca System For Fecal Incontinence Receives 510(k) Clearance

Curon Medical's 12 sales reps will market the Secca system for the treatment of fecal incontinence. FDA 510(k) clearance was announced March 25

Coronavirus Demanding Focus Of US FDA’s Antiviral, Other Divisions

Office of New Drugs Director Peter Stein said in an interview that a large amount of coronavirus-related work is arriving at the FDA, but so far staff are keeping up.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts